The 7th annual Patients as Partners is guided by a dedicated group of advisors from pharma and biotech, patient advocacy and FDA whom meet quarterly to develop the conference agenda. This is the only event that truly demonstrates how patient involvement gets done throughout the entire medicines development life cycle to drive greater efficiencies in clinical research.

The program delves deep into patient involvement ideas, strategies and implementation processes that biopharma can utilize in order to help advance patient participation for better clinical outcomes. Each session demonstrates the what, where, when and how to co-create solutions with patients and measure the impact of those initiatives.

Connect with WCG at the conference

  • Please see below for a list of WCG’s speaking sessions at the event.

WCG Speaking Session's at Patients As Partners US

Thursday, August 20th

A New Platform to Track Patient Recruitment Effectiveness and Connect Patients into Clinical Trials Leveraging an “Open Table” Model
Time: 1:15 PM – 1:30 PM
Speaker: Lisa La Luna
SVP, Patient Advocacy, SME & Senior Advisor, WCG

Can a Global Pandemic Improve Patient Access to Clinical Trials?
Time: 3:00 PM – 3:30 PM
Speaker: Lisa La Luna
SVP, Patient Advocacy, SME & Senior Advisor, WCG